亚洲精品成人免费_91女神娇喘疯狂3p之夜_精品韩国一级久久_av毛片网_www超碰com_午夜视频体内射.COM.COM

美國Clontech        2005年7月1日，日本最大的生物工程公司TaKaRa公司宣布花費6千萬美元成功從BD Biosciences收購Clontech單元。此收購計劃已經于2005年8月底完成，Clontech已成為TaKaRa全資子公司。
美國Clontech是1984年由華人方瑞賢創辦的，一度曾經是眾多海外華人的驕傲。因為方瑞賢創辦的是全美第一家，也是亞裔創辦的最大的分子生物公司，更重要的是Clontech 建立了生物技術中建立基因文庫的模式。在Clontech 被BD收購時已有四百名員工，包括六十五位博士，擁有五十多項專利，產品已達兩千多種，堪稱全球數一、數二的基因庫，提供全球三十多個國家基因實驗室或是學術界做研究之用。該公司有曾于一九九四、一九九五、一九九八及一九九九年被圣荷西及舊金山商業報紙選為一百個成長最快的私人公司。Clontech公司一直銳意進取，其開發的產品多次獲得全美R&D100金獎。產品范圍包括基因識別、基因表達、基因功能研究，大家熟悉的Smart Race，Altas DNA矩陣，SSH消減雜交、MTN膜、多色熒光蛋白載體、MatchMaker酵母雙雜交系列也在其中。
TaKaRa于1979年從生產限制性內切酶起步，首先將PCR技術引入日本市場，并逐漸成為日本生命科學研究領域領先的公司。TaKaRa在2004財政年度試劑銷售達到118億日元（1億美元左右），其中85％的收益來自于日本本土市場，其他有部分來自于中國等亞洲市場。
此次收購會給Takara帶來以下收益：極大地豐富Takara原來的產品線；迅速擴增TaKaRa在歐美市場的份額，因為Clontech 70％以上的銷售是來自于歐美，而Takara 85％的收益來自于日本本土市場。本次收購將全面擴展日本產品在歐美的銷售。另外Takara將整合并加強日本本土和位于美國的Clontech研發部，加快產品的開發，提高Takara在全球生命科學研究市場的份額。

美國Clontech公司是一家專門致力于基因工程及蛋白質工程領域研究用產品的研發和生產的專業公司。公司產品涉及PCR產品、RT－PCR產品、cDNA文庫構建、基因克隆、基因表達、基因分析、蛋白質技術等諸多領域。產品種類多達2000多種。Clontech公司擁有多種獨立知識產權產品，其強大的科研實力和完善的質量管理體系（ISO9001）為Clontech產品的良好品質提供了可靠保障。



  

Clontech Laboratories, Inc.
Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clontech joins a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Clontech’s mission is to develop high-quality innovative tools and services to accelerate discovery.

Innovation
In order to maintain our position as an industry leader, we foster an environment of collaboration and discovery for our research scientists and with the research community at large. Our scientists are leaders in their fields and publish regularly in leading peer-reviewed journals such as Biotechniques, Science, and PNAS. Clontech holds over 30 patents and offers novel tools for studying gene expression analysis, subcellular localization, apoptosis, and signal transduction. In addition, our scientists have authored guides and publications that are industry standards in technologies ranging from PCR to gene expression profiling to yeast two-hybrid systems.

We actively seek research and business partnerships with industry innovators and leaders. Our research and development efforts have resulted in award winning technologies and the introduction of novel tools to the market. Clontech introduced the first commercially available antibody microarray, a unique tool that allows users to study hundreds of cellular proteins in one experiment. We have also received R&D 100 awards for our fluorescent proteins, apoptosis detection systems, cDNA arrays, tet-regulated gene expression systems, and retroviral expression systems.

Quality
Clontech is committed to understanding and meeting the quality needs and expectations of all of our customers. To guarantee continuous process improvement, we have established a comprehensive quality assurance program to meet our commitment to total customer satisfaction as well as the requirements of ISO 9001:2000. Continuous quality improvement is the responsibility of every employee and we build quality into each and everything we do. To view our ISO 9001:2000 certificate, click here.

Service
Our commitment to service is our commitment to our customers. Our customer service groups interact with all levels of the company to ensure that every process is focused on delivering the highest level of service and satisfaction. Our technical support team is comprised mainly of Ph.D. scientists, including many with years of post-doctoral experience. From order placement to technical support, we meet and exceed industry standards for timely and helpful responses to customer inquiries. We provide custom products, services, and packaging to better suit our customers’ needs. In short, we view every contact point as an opportunity to provide excellent service to our customers.